The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection
NCT04769245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2021-02-24
Summary
Pathogen-free, concentrated, pooled convalescent plasma has higher SARS-CoV2 antibody titers and neutralizing antibody activities, without requiring blood group compatibility that allows patient accessibility in a shorter time and has safe plasma characteristic.
Conditions
- Covid19
Sponsors & Collaborators
-
Acıbadem Labcell
collaborator OTHER -
Acibadem University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-18
- Primary Completion
- 2021-04-01
- Completion
- 2021-06-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Convalescent Plasma Treatment in COVID-19
NCT04476888 ·Status: COMPLETED ·Phase: NA
-
Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19
NCT05648097 ·Status: RECRUITING ·Phase: NA
-
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19
NCT04567173 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome
NCT04380935 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients
NCT04345523 ·Status: COMPLETED ·Phase: PHASE2
-
Antiseptic Scrub Contamination and Transmission Trial
NCT02645214 ·Status: COMPLETED ·Phase: NA
-
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.
NCT04374526 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
UVA Light Device to Treat COVID-19
NCT04572399 ·Status: COMPLETED ·Phase: NA
-
Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria
NCT01481935 ·Status: COMPLETED ·Phase: NA
-
Effect of Chlorhexidine Solution in Preventing Peripheral Venous Catheter Associated-Infection
NCT05441605 ·Status: COMPLETED ·Phase: NA
-
The Effect of Plasma-air-filtration on the Incidence of Surgical Site Infections in Orthopaedic Surgery
NCT02695368 ·Status: COMPLETED ·Phase: NA
-
Implementation of CareCube Negative Pressure Isolation Units
NCT05229926 ·Status: COMPLETED
-
Use of Disposable Cuff Cover to Prevent Carriage of Pathogen Microorganisms Originated by Cuffs
NCT05326945 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients
NCT01989416 ·Status: COMPLETED ·Phase: PHASE3
-
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
NCT04665960 ·Status: COMPLETED
-
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
NCT04896866 ·Status: COMPLETED ·Phase: NA
-
Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic
NCT04431310 ·Status: UNKNOWN
-
Organosilane for Surface Cleaning in Intensive Care Units
NCT05673226 ·Status: COMPLETED ·Phase: NA
-
Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method
NCT04212130 ·Status: COMPLETED ·Phase: NA
-
Efficacy Of Copper To Reduce Acquisition Of Microbes and Healthcare-acquired Infections
NCT01565798 ·Status: COMPLETED ·Phase: NA
-
Skin Prep to Reduce Postoperative Shoulder Infection
NCT02510144 ·Status: COMPLETED ·Phase: NA
-
Medical Students and Risk of COVID-19 Infection
NCT04967586 ·Status: COMPLETED
-
Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2
NCT05745467 ·Status: WITHDRAWN ·Phase: PHASE4
-
IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles
NCT02627092 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series
NCT05046652 ·Status: COMPLETED